Flonase Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS ® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions
Conditions:   Asthma;   Bioequivalence Interventions:   Drug: Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals;   Drug: FLOVENT DISKUS Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2021 Category: Research Source Type: clinical trials